KEIICHI MATSUO

1.3k citations
15 papers · 1.1k indexed · 1 hit paper · h-index 13
Topics
Thyroid Cancer Diagnosis and Treatment (7 papers)Growth Hormone and Insulin-like Growth Factors (5 papers)Cancer-related Molecular Pathways (5 papers)

In The Last Decade

KEIICHI MATSUO

15 papers receiving 1.0k citations

Hit Papers

High prevalence of mutations of the p53 gene in poorly di...19932026200420151993100200300400500

Peers

KEIICHI MATSUO
Comparison fields: 5 of 60
  • Endocrinology, Diabetes and Metabolism 737
  • Oncology 507
  • Molecular Biology 405
  • Genetics 221
  • Pathology and Forensic Medicine 216
Replace M.H. Goyns with:
M.H. Goyns United Kingdom
H Stobbe Germany
Paul Naik United States
Wendy van Veelen Netherlands
K. J. Cullen United States
S Takai Japan
J A Ruizeveld de Winter Netherlands
Paul V. Newcomb United Kingdom
Hein F.B.M. Sleddens Netherlands
Thai H. Tran United States
KEIICHI MATSUO relative to M.H. Goyns United Kingdom M.H. Goyns's profile →
Citations per field
00.5×2.9×
M.H. Goyns · 1×
Citations per year

Countries citing papers authored by KEIICHI MATSUO

Since Specialization
Citations

This map shows the geographic impact of KEIICHI MATSUO's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KEIICHI MATSUO with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KEIICHI MATSUO more than expected).

Fields of papers citing papers by KEIICHI MATSUO

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by KEIICHI MATSUO. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KEIICHI MATSUO. The network helps show where KEIICHI MATSUO may publish in the future.

Co-authorship network of co-authors of KEIICHI MATSUO

This figure shows the co-authorship network connecting the top 25 collaborators of KEIICHI MATSUO. A scholar is included among the top collaborators of KEIICHI MATSUO based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with KEIICHI MATSUO. KEIICHI MATSUO is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 20
2 2
3 23
4 64
5 23
6
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.breakdown →
534
7
Lack of expression of tumor-suppressor genes in human malignant glioma cell lines.
33
8 63
9 117
10 87
11 16
12 34
13 24
14 23
15 7

About KEIICHI MATSUO

KEIICHI MATSUO is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (7 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (737 citations), Oncology (507 citations) and Pathology and Forensic Medicine (216 citations). KEIICHI MATSUO has collaborated with scholars based in United States, Japan and Argentina. Frequent co-authors include James A. Fagin, Shanhong Tang, H. Phillip Koeffler, D.L. Chen, Hiroyuki Namba, R. Gutman, Shigenobu Nagataki, Pablo V. Gejman, Eitan Friedman and Shunichi Yamashita. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026